UK IPO launches call for views on the Designs System UK IPO launches call for views on the Designs System Reviewed by Hayleigh Bosher on Monday, January 31, 2022 Rating: 5
No IP, no right to information? CJEU to clarify scope of article 8 Enforcement Directive No IP, no right to information? CJEU to clarify scope of article 8 Enforcement Directive Reviewed by Jan Jacobi on Monday, January 31, 2022 Rating: 5

Sunday Surprises

January is nearly over and it seems almost impossible to catch up with how fast time is going by. However, it is never impossible to catch u...
- Sunday, January 30, 2022
Sunday Surprises Sunday Surprises Reviewed by Alexandre Miura on Sunday, January 30, 2022 Rating: 5
Never Too Late: If you missed the IPKat the past 2 weeks! Never Too Late: If you missed the IPKat the past 2 weeks! Reviewed by Giorgio Luceri on Sunday, January 30, 2022 Rating: 5
General Court to decide whether consumables are component parts of complex products (T-617/21) General Court to decide whether consumables are component parts of complex products (T-617/21) Reviewed by Anastasiia Kyrylenko on Sunday, January 30, 2022 Rating: 5
Chanel is reminded: trademark territoriality still matters Chanel is reminded: trademark territoriality still matters Reviewed by Neil Wilkof on Thursday, January 27, 2022 Rating: 5
Volkswagen is a happy camper as BoA upholds its EU trade mark opposition  Volkswagen is a happy camper as BoA upholds its EU trade mark opposition Reviewed by Becky on Tuesday, January 25, 2022 Rating: 5
Using that classic piece of art on a book cover: Grr… Using that classic piece of art on a book cover: Grr… Reviewed by Neil Wilkof on Tuesday, January 25, 2022 Rating: 5
EU General Court upholds finding of partial invalidity of the Moon Boot shape trade mark EU General Court upholds finding of partial invalidity of the Moon Boot shape trade mark Reviewed by Eleonora Rosati on Monday, January 24, 2022 Rating: 5
Düsseldorf Regional Court grants second-medical use injunctions for Novartis Afinitor cancer treatment Düsseldorf Regional Court grants second-medical use injunctions for Novartis Afinitor cancer treatment  Reviewed by Annsley Merelle Ward on Monday, January 24, 2022 Rating: 5

Monday Miscellany

Some of us may be counting the days till it's finally spring, but this Kat is still enjoying the wonders of winter. While spring is not ...
- Monday, January 24, 2022
Monday Miscellany Monday Miscellany Reviewed by Alexandre Miura on Monday, January 24, 2022 Rating: 5
The challenge of patenting combination claims at the EPO The challenge of patenting combination claims at the EPO Reviewed by Rose Hughes on Monday, January 24, 2022 Rating: 5
Reminder to vote for IPKat Book of the Year Awards 2021 Reminder to vote for IPKat Book of the Year Awards 2021 Reviewed by Hayleigh Bosher on Monday, January 24, 2022 Rating: 5

Around the IP Blogs

Although a bleak winter week, the IPKat is here to warm you up with tales of interesting posts from the IP blogs.   TRADE MARKS Following a ...
- Sunday, January 23, 2022
Around the IP Blogs Around the IP Blogs Reviewed by Giorgio Luceri on Sunday, January 23, 2022 Rating: 5
Book review: Performers' Rights Book review: Performers' Rights Reviewed by Hayleigh Bosher on Friday, January 21, 2022 Rating: 5
Off we go! The Unified Patent Court is officially born.  Off we go! The Unified Patent Court is officially born. Reviewed by Frantzeska Papadopoulou on Thursday, January 20, 2022 Rating: 5
[Guest post] The new German competition tool in action – Ensuring the effectiveness of the new press publisher’s neighbouring right against Google [Guest post] The new German competition tool in action – Ensuring the effectiveness of the new press publisher’s neighbouring right against Google Reviewed by Tian Lu on Tuesday, January 18, 2022 Rating: 5
Urgent requests for declaration of non infringement (DNI)? Frequently DeNIed… Urgent requests for declaration of non infringement (DNI)? Frequently DeNIed… Reviewed by Gabriele Girardello on Tuesday, January 18, 2022 Rating: 5
Powered by Blogger.